食管胃底静脉曲张破裂出血预防和治疗进展*

doi:10.3969/j.issn.1672-5069.2021.04.039

Abstract

Abstract: Objective Esophageal and gastric varices bleeding (EGVB) is a common complications of liver cirrhosis, with a high mortality rate. Therefore, the prevention and treatment of EGVB is very important for patients with liver cirrhosis. Internal medicine, endoscopic management, interventional and surgical operation are all important approaches for the prevention and treatment of EGVB, which greatly improves the survival rate of cirrhotic patients. In this paper, we reviewed the current progress of primary prevention, emergent hemostasis and secondary prevention of patients with different types of esophageal and gastric varices.

Key words: Liver cirrhosis, Esophagogastric varices, Primary prevention, Emergent hemostasis, Secondary prevention

Sun Ruonan, Zhang Chunqing. Prevention and treatment of cirrhotics with esophagus and gastric varices bleeding[J]. Journal of Practical Hepatology, 2021, 24(4): 607-610.

References

[1] Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology, 2008,134(6):1715-1728.
[2] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guid- ance by the American Association for the study of liver diseases. Hepatology,2017,65(1):310-335.
[3] Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology,1992,16(6):1343-1349.
[4] Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Epatol,1991,13(3):274-278.
[5] Sharma BC, Varakanahalli S, Singh JP, et al. Gastric varices in cirrhosis vs. extrahepatic portal venous obstruction and response to endoscopic N-butyl-2-cyanoacrylate injection. J Clin Exp Hepatol,2017,7(2):97-101.
[6] Karadsheh Z, Allison H. Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding. N Am J Med Sci,2013,5(10):573-579.
[7] Bañares R, Moitinho E, Matilla A, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology,2002,36(6):1367-1373.
[8] Shah HA, Azam Z, Rauf J, et al. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. J Hepatol,2014,60(4):757-764.
[9] Bai M,Qi X,Yang M,et al. Combined therapies versus monotherapies for the first variceal bleeding in patients with high- risk varices:a meta- analysis of randomized controlled trials. J Gastroenterol Hepatol,2014,29(3):442- 452.
[10] Santos MM, Tolentino LH, Rodrigues RA, et al. Endoscopic treatment of esopha- geal varices in advanced liver disease patients: band ligation versus cyanoacry- late injection. Eur J Gastroenterol Hepatol,2011,23(1):60-65.
[11] de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol,2015,63(3):743-752.
[12] Mishra SR, Sharma BC, Kumar A, et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol,2011,54(6):1161-1167.
[13] European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol,2018,69(2): 406-460.
[14] Dai C, Liu WX, Jiang M, et al. Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage:a meta-analysis. World J Gastroenterol,2015,21(8):2534-2541.
[15] 庄辛福,张宝东,程文芳.套扎与硬化对肝硬化食管静脉曲张疗效的Meta分析.胃肠病学和肝病学杂志,2013,22( 4) :375-379.
[16] Rios Castellanos E, Seron P, Gisbert JP, et al. Endoscopic injection of cyanoac- rylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database Syst Rev,2015,(5):CD010180.
[17] Binmoeller KF, Weilert F, Shah JN, Kim J. EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos). Gastrointest Endosc,2011,74(5):1019-1025.
[18] Robles-Medranda C, Oleas R, Valero M, et al. Endoscopic ultrasonography-guided deployment of embolization coils and cyanoacrylate injection in gastric varices versus coiling alone: a randomized trial. Endoscopy,2020,52(4):268-275.
[19] 冯凯祥,于剑波,杨培,等.聚桂醇纤维蛋白原凝血酶序贯法治疗胃底静脉曲张出血.西南国防医药,2017,27(01):8-11.
[20] Kapoor A, Dharel N, Sanyal AJ. Endoscopic diagnosis and therapy in gastroesophageal variceal bleeding. Gastrointest Endosc Clin N Am,2015,25(3):491-507.
[21] Garcia-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol,2013,58(1):45-50.
[22] Lyu Y, Yang Z, Liu L, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol,2019,4(8):587-598.
[23] Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol,2002,37(5):703-704.
[24] 石青,郭武华.介入治疗肝硬化门脉高压症并发食管胃底静脉曲张破裂出血研究进展.实用肝脏病杂志,2016,19( 5) : 519-523.
[25] Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet,2003,361(9361):952-954.
[26] Bernard B, Lebrec D, Mathurin P, et al. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology,1997,25(1):63-70.
[27] Thiele M, Krag A, Rohde U, et al. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Aliment Pharmacol Ther,2012,35(10):1155-1165.
[28] Gonzalez R, Zamora J, Gomez-Camarero J, et al. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med,2008,149(2):109-122.
[29] Lin LL, Du SM, Fu Y, et al. Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget,2017,8(34):57399-57408.
[30] Michael PG, Antoniades G, Staicu A, et al. Pulmonary glue embolism: An unusual complication following endoscopic sclerotherapy for gastric varices. Sultan Qaboos Univ Med J,2018,18(2):e231-e235.
[31] 章復龙,朱元东,徐晶,等.组织胶联合金属夹治疗孤立性胃底静脉曲张(IGV1型)21例疗效分析.中国内镜杂志,2017,23(7):100-103.
[32] 施言,吴乾能,谢欣城,等.内镜下钛夹联合组织胶治疗GOV2型胃底静脉曲张30例.中国内镜杂志,2017,23(12):88-92.
[33] McCarty TR, Bazarbashi AN, Hathorn KE, et al. Combination therapy versus monotherapy for EUS-guided management of gastric varices: A systematic review and meta-analysis. Endosc Ultrasound,2020,9(1):6-15.
[34] Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy,2007,39(8):679-685.
[35] Sabri SS, Abi-Jaoudeh N, Swee W, et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol,2014,25(3):355-361.

Prevention and treatment of cirrhotics with esophagus and gastric varices bleeding

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Ying, He Xian, Tian Zhiying, et al. Clinical features and risk factors of acute kidney injury in patients with viral hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(4): 524-527.
[2]	Jin Susu, Yan Huadong. Increased serum pro-adrenomedullin level is helpful for the diagnosis of bacterial infection and indicator for poor short-term prognosis in patients with decompensated cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(4): 528-531.
[3]	Jiang Qiuwei, Huang Li, Yao Chaoguang. Clinical features and risk factors of esophagogastric variceal bleeding in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(4): 532-535.
[4]	Feng Juan, Halida Xiaerfuhazi, Fan Xiaotang, et al. Serum leptin level in patients with hepatitis B liver cirrhosis and concomitant metabolic associated fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(4): 536-539.
[5]	Gao Huiru, Gao Huibin, Peng Zhao, et al. Clinical feature and impacting factors of esophageal and gastric variceal bleeding in patients with hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(3): 395-398.
[6]	Wang Yunqiang, Wang Liping, Huang Dongmei, et al. Changes ofportal hemodynamics in patients with hepatitis B cirrhosis after transjugular intrahepatic portosystemic stent-shunt [J]. Journal of Practical Hepatology, 2021, 24(3): 399-402.
[7]	Wu Chang, Zhang Yuan’an, Peng Chunfen. Efficacy of endoscopic variceal ligation and carvedilol maintenance in the treatment of patients with liver cirrhosis and esophagogastric variceal bleeding [J]. Journal of Practical Hepatology, 2021, 24(3): 403-406.
[8]	Nan Dong, Hong Jinling, Jiang Haiyu. Efficacyof DCE-MRI in evaluating severity of gastroesophageal varices in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(3): 407-410.
[9]	Li Hua, Wen Jianghua, Wu Yingchun, et al. Clinical features of patients with alcoholic cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(3): 411-414.
[10]	Zhao Kai, Xue Jinfeng, Xue Pengfei, et al. Application of Viatorr covered stent in TIPS for treatment of cirrhotics with portal hypertension [J]. Journal of Practical Hepatology, 2021, 24(3): 419-422.
[11]	Xie Ning, Huang Juanxiu, Yan Liumei, et al. Risk factors of liver cancer occurrence in patients with hepatitis B liver cirrhosis receiving long-term nucleot(s)ide antiviral therapy [J]. Journal of Practical Hepatology, 2021, 24(3): 423-426.
[12]	Wang Jiangli, Pei Lingyan, He Jingjing, et al. Clinical value of serum PTX3 and sTWEAK in predicting death of patients with decompensated hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(2): 236-239.
[13]	Song Jinyun, Wang Jianfang, Zhao Hongyu. Hepatitis B viralgenotypes in patients with chronic hepatitis B and cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(1): 87-90.
[14]	Wei Rongrong, Li Ailing, Li Hong, et al. Changes and clinical significance of indocyanine green clearance test in patients with chronic viral hepatitis, liver cirrhosis and liver failure [J]. Journal of Practical Hepatology, 2021, 24(1): 91-94.
[15]	Zhang Xin, Guo Yue, Yang Jun. Evaluation ofesophageal and gastric varices by liver and splenic stiffness measurement by elastography in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(1): 95-98.